Ipamorelin

GH Axis

GH release with lower appetite/prolactin profile than older GHRPs

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Peptide
Primary mechanism: Ghrelin receptor agonism
Primary market use: Hormone optimization

Pharmacology

Molecular weight (Da): 711.9
Oral bioavailability: N/A
Half-life: ~2 h
Route tags: Route-dependent / verify
Evidence level: Research
Clinical status: Experimental/compounded
Value-for-money score: 5 / 10

Reported protocol signal

Treatment length: no longer than 8 weeks, with equal time off SQ: • 200 mcg nightly (5 nights on, 2 nights off) (Tailor Made Compounding Catalog) • 200-300 mcg one to three times a day (Jay Campbell) Start at a lower dose due to possible allergic reaction. Inject SLOWLY Ipamorelin is often stacked with CJC-1295 no DAC: SQ: • 200mcg/200mcg nightly (5 nights on, 2 nights off) (Tailor Made Compounding Catalog) Wait 2-3 hours after eating, and don’t eat for another 30 minutes after injection

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Transient secretagogue

Sources

https://pubmed.ncbi.nlm.nih.gov/